Announcement
Phaze announced an iOS app in April 2026 aimed at people using GLP-1 medications. Its release described tools for logging doses, weight, meals, and side effects, along with charts intended to show how recorded information changes over time. The company also described an AI-assisted meal-entry feature and reports that users could share with a clinician.
The announcement framed the app as a way to organize personal records during a medication course. Apple's App Store listing confirms the existence of the Phaze GLP-1 Weight Tracker app and describes tracking features, although app capabilities, availability, and subscription terms can change after a launch. Users should review the current listing and privacy information before entering health data.
The original promotional release made claims about clinical value, medication blood concentration, privacy law compliance, ratings, and weight-loss outcomes. Those claims are not established by the announcement itself and are not repeated here as medical or technical facts. A tracking chart is not a measurement of an individual patient's blood level, and app suggestions should not replace care from a licensed clinician.
The linked syndicated release records what Phaze announced on April 6, 2026. This archive is historical product news, not medical advice, an endorsement of the app, or a statement that any advertised feature or price remains current.